Syneos Health Inc. (NASDAQ:SYNH) finished Friday with an addition of $0.68 to close at $89.53, an upside of 0.77 percent. An average of 390,780 shares of common stock have been traded in the last five days. There was a gain of $1.82 in the past week, and it reached a new high 45 times over the past 12 months. The last 20 days have seen an average of 462,150 shares traded, while the 50-day average volume stands at 512,304.
SYNH stock has decreased by -6.76% in the last month. The company shares reached their 1-month lowest point of $85.19 on 10/01/21. With the stock rallying to its 52-week high on 09/14/21, shares of the company touched a low of $51.04 and a high of $97.47 in 52 weeks. It has reached a new high 35 times so far this year and achieved 31.41% or $21.40 in price. In spite of this, the price is down -8.15% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
50 days have passed since Syneos Health Inc. (SYNH) last reported insider trading activity. Kralowetz Donna Hildebrand, who is SVP, Chief Accounting Officer, most recently acquired $248 shares at $94.30 per share on Sep 03. In this transaction, the insider spent $23,386. Chief Financial Officer, Meggs Jason M., disposed of 9,223 shares at a price of $95.00 on Sep 03. The insider now owns more than $876,185 worth of shares. Prior to that, Chief Executive Officer Macdonald Alistair went on to Sale 35,553 shares at $87.96 each on Aug 03. An amount of $3,127,268 was transacted.
Syneos Health Inc. (SYNH) has a trailing price-to-earnings (P/E) ratio of 39.99, which compares with the 26.50 for the broader industry and 33.43 for the sector. In the last five years, Syneos Health Inc.’s PE ratio has ranged between 346.19 and 18.55. The stock’s beta is 1.80. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.98, the price-to-book (PB) ratio at 2.87, and the price-to-cash flow ratio at 21.09.
The quick ratio of Syneos Health Inc. for the three months ended June 29 was 1.10, and the current ratio was 1.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.89 and a total debt to equity ratio of 0.90 for the quarter ending June 29. Syneos Health Inc.’s EBITDA margin for the year ending June 29 is 13.02%, while its operating margin for the same period stands at 7.40%. Its gross profit as reported stood at $1.02 billion compared to revenue of $4.42 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Syneos Health Inc.’s return on assets was 3.00%. For the broader industry, ROE averaged -2.89 over the past year.
For the three-month period that ended June 29, Syneos Health Inc. had $2.86 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $41.91 million in the quarter, while revenues of $38.72 million were grew 90.67%. The analyst consensus anticipated Syneos Health Inc.’s latest quarter earnings to come in at $0.95 per share, but it turned out to be $0.97, a 2.10% surprise. For the quarter, EBITDA amounted to $141.4 million. Shareholders own equity worth $103.48 million.
From a technical analysis perspective, let’s take a brief look at Syneos Health Inc. (SYNH) price momentum. RSI 9-day as of the close on 22 October was 56.72%, suggesting the stock is Neutral, with historical volatility in this time frame at 14.01%.
As of today, SYNH’s price is $88.15 +2.08% or $1.82 from its 5-day moving average. SYNH is currently trading -7.04% lower than its 20-day SMA and +4.64% higher than its 100-day SMA. However, the stock’s current price level is +3.19% above the SMA50 and +24.94% above the SMA200.
The stochastic %K and %D were 67.06% and 54.68%, respectively, and the average true range (ATR) was 2.12. With the 14-day stochastic at 81.11% and the average true range at 2.24, the RSI (14) stands at 51.51%. The stock has reached 0.84 on the 9-day MACD Oscillator while the 14-day reading was at 1.09.
The consensus rating for Syneos Health Inc. (SYNH) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SYNH, while 2 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 7 others rate it as a “buy”.
What is SYNH’s price target for the next 12 months?
Analysts predict a range of price targets between $93.00 and $115.00, with a median target of $100.00. Taking a look at these predictions, the average price target given by analysts for Syneos Health Inc. (SYNH) stock is $102.00.